 | | PRD_002337 | | Name: | INHIBITOR ARC-1411 | | Formula: | C61 H119 N34 O9 | | Definition date: | 2024-04-10 | | Last modified: | 2024-04-10 |
|
 | | PRD_002339 | | Name: | Inhibitor ARC-1415 | | Formula: | C55 H106 N30 O8 | | Definition date: | 2024-04-10 | | Last modified: | 2024-04-10 |
|
 | | PRD_002532 | | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | | Formula: | C59 H100 N13 O15 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
 | | PRD_002557 | | Name: | Stapled peptide | | Formula: | C80 H104 N27 O17 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
 | | PRD_002559 | | Name: | Stapled peptide | | Formula: | C75 H105 N26 O17 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
 | | PRD_002533 | | Name: | Deacylated Microviridin J | | Formula: | C67 H97 N17 O20 | | Definition date: | 2024-02-14 | | Last modified: | 2024-02-14 |
|
 | | PRD_002473 | | Name: | Agrocinopine A (beta-L-arabinopyranose form) | | Formula: | C17 H31 O18 P | | Description: | phosphodiester of sucrose and L-arabinose | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002485 | | Name: | [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | | Formula: | C21 H34 N6 O16 P2 | | Description: | unusual glycan purine conjugate (containing GLC and ADE) | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002506 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-4-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002507 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002508 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-3-yl phosphate; beta-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002547 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; alpha-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-alpha-glucose (ALX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002548 | | Name: | Agrocinopine C-like (D-glucos-2-yl sucros-1-yl phosphate; beta-D-glucose form) | | Formula: | C18 H33 O19 P | | Description: | Phosphodiester of D-beta-glucose (BNX) and sucrose (GLC-FRU). | | Definition date: | 2024-01-24 | | Last modified: | 2024-01-24 |
|
 | | PRD_002517 | | Formula: | C66 H84 N10 O17 S | | Definition date: | 2023-12-06 | | Last modified: | 2023-12-06 |
|
 | | PRD_002466 | | Name: | Cyclohexyl-Griselimycin | | Formula: | C63 H106 N10 O12 | | Definition date: | 2023-11-29 | | Last modified: | 2023-11-29 |
|
 | | PRD_002467 | | Name: | Mycoplanecin A | | Formula: | C61 H102 N10 O13 | | Definition date: | 2023-11-29 | | Last modified: | 2023-11-29 |
|
 | | PRD_002417 | | Name: | Ac-VRHA-conh-[4-(4-butyl)-phenoxy-1-phenyl-2-butyl] | | Formula: | C43 H66 N10 O7 | | Definition date: | 2023-10-25 | | Last modified: | 2023-10-25 |
|
 | | PRD_002387 | | Name: | tert-butyl N-[5-phenyl-3-(2-phenylethylcarbamoyl)thiophen-2-yl]carbamate | | Formula: | C24 H26 N2 O3 S | | Definition date: | 2023-09-27 | | Last modified: | 2023-09-27 |
|
 | | PRD_002443 | | Name: | SiaLac-amidine-Lys | | Formula: | C33 H57 N5 O20 S | | Definition date: | 2023-09-27 | | Last modified: | 2023-09-27 |
|
 | | PRD_002426 | | Name: | Corramycin | | Formula: | C51 H81 N11 O21 | | Definition date: | 2023-08-16 | | Last modified: | 2023-08-16 |
|
 | | PRD_002431 | | Name: | Cyclic tetraadenosine monophosphate (cA4) | | Formula: | C40 H48 N20 O24 P4 | | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-03 |
|
 | | PRD_002432 | | Name: | Pam3-SKKKK | | Formula: | C81 H160 N10 O13 S | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002528 | | Name: | 142D6 | | Formula: | C26 H37 F N4 O6 S | | Description: | Lys-covalent pan-IAP inhibitor | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002527 | | Name: | Intermediate for maxamycins synthesis | | Formula: | C84 H114 Cl2 N8 O17 S Si2 | | Definition date: | 2023-07-05 | | Last modified: | 2023-07-05 |
|
 | | PRD_002484 | | Name: | [(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | | Formula: | C21 H34 N6 O16 P2 | | Description: | unusual glycan purine conjugate (containing BGC and ADE) | | Definition date: | 2023-06-14 | | Last modified: | 2023-06-14 |
|
